Blog
RSS FeedPosted by Michael Wonder on 01 Jun 2020
Health economic assessment of Vimizim in mucopolysaccharidosis type IVA (Morquio A syndrome)
29 May 2020 - TLV has developed a health economic knowledge base for the regions of the drug Vimizim (elosulfase alfa) ...
Posted by Michael Wonder on 31 May 2020
Johnson & Johnson receives positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
29 May 2020 - The investigational Ebola vaccine regimen leverages Janssen’s established AdVac and PER.C6 technologies and Bavarian Nordic’s MVA-BN technology. ...
Posted by Michael Wonder on 31 May 2020
Highlights from the May 25-28 CHMP meeting
29 May 2020 - Eight new medicines recommended for approval. ...
Posted by Michael Wonder on 28 May 2020
TLV has decided to reconsider the subsidy status for certain drugs
26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...
Posted by Michael Wonder on 27 May 2020
NICE issues final guidance on NHS use of Bayer's Vitrakvi
27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...
Posted by Michael Wonder on 27 May 2020
NICE recommends treatment for type of small-cell lung cancer
27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...
Posted by Michael Wonder on 27 May 2020
EMA publishes agenda for 25-28 May 2020 CHMP meeting
27 May 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 26 May 2020
ICER releases draft evidence report on ulcerative colitis therapies
26 May 2020 - Public comment period now open until 29 July 2020; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 26 May 2020
NICE Chairman Sharmila Nebhrajani begins her new role
26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...
Posted by Michael Wonder on 25 May 2020
SMC response to COVID-19
22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the ...
Posted by Michael Wonder on 25 May 2020
CADTH sees green for Beovu
25 May 2020 - CADTH has published its final recommendation for Novartis' Beovu. ...
Posted by Michael Wonder on 22 May 2020
Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE
22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...
Posted by Michael Wonder on 21 May 2020
CADTH posts final recommendation for Entyvio
21 May 2020 - CADTH has completed its consideration of subcutaneous vedolizumab for the treatment of adult patients with moderately to ...
Posted by Michael Wonder on 21 May 2020
ISPOR holds its first completely virtual conference
21 May 2020 - Virtual ISPOR 2020 plenaries focused on health policy, big data and artificial intelligence, cost effectiveness analysis and ...
Posted by Michael Wonder on 20 May 2020
Cost-effectiveness evaluation for pricing medicines and devices: a new value-based price adjustment system in Japan
18 May 2020 - In Japan, a new cost-effectiveness evaluation system for medicine and medical device pricing was employed in April ...